Lafayette Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $368K | Hold |
1,691
| – | – | 0.07% | 118 |
|
|
2025
Q4 | $386K | Sell |
1,691
-250
| -13% | -$57K | 0.07% | 116 |
|
|
2025
Q3 | $449K | Sell |
1,941
-200
| -9% | -$40.7K | 0.09% | 103 |
|
|
2025
Q2 | $397K | Hold |
2,141
| – | – | 0.08% | 109 |
|
|
2025
Q1 | $449K | Sell |
2,141
-101
| -5% | -$19.6K | 0.09% | 98 |
|
|
2024
Q4 | $398K | Hold |
2,242
| – | – | 0.09% | 99 |
|
|
2024
Q3 | $443K | Hold |
2,242
| – | – | 0.09% | 95 |
|
|
2024
Q2 | $385K | Sell |
2,242
-68
| -3% | -$11.3K | 0.09% | 101 |
|
|
2024
Q1 | $421K | Hold |
2,310
| – | – | 0.09% | 93 |
|
|
2023
Q4 | $358K | Hold |
2,310
| – | – | 0.09% | 95 |
|
|
2023
Q3 | $344K | Buy |
2,310
+150
| +7% | +$22K | 0.09% | 95 |
|
|
2023
Q2 | $291K | Hold |
2,160
| – | – | 0.08% | 100 |
|
|
2023
Q1 | $344K | Hold |
2,160
| – | – | 0.1% | 92 |
|
|
2022
Q4 | $349K | Hold |
2,160
| – | – | 0.1% | 91 |
|
|
2022
Q3 | $290K | Sell |
2,160
-200
| -8% | -$28.7K | 0.09% | 94 |
|
|
2022
Q2 | $361K | Hold |
2,360
| – | – | 0.1% | 87 |
|
|
2022
Q1 | $383K | Sell |
2,360
-650
| -22% | -$94.4K | 0.1% | 92 |
|
|
2021
Q4 | $408K | Buy |
3,010
+200
| +7% | +$23.6K | 0.1% | 94 |
|
|
2021
Q3 | $303K | Hold |
2,810
| – | – | 0.08% | 98 |
|
|
2021
Q2 | $317K | Buy |
+2,810
| New | +$316K | 0.09% | 97 |
|
|
2019
Q3 | – | Sell |
-10,715
| Closed | -$779K | – | 87 |
|
|
2019
Q2 | $779K | Hold |
10,715
| – | – | 0.28% | 49 |
|
|
2019
Q1 | $864K | Buy |
10,715
+47
| +0.4% | +$3.85K | 0.32% | 50 |
|
|
2018
Q4 | $983K | Buy |
10,668
+592
| +6% | +$52.1K | 0.39% | 47 |
|
|
2018
Q3 | $953K | Buy |
10,076
+5,452
| +118% | +$517K | 0.33% | 48 |
|
|
2018
Q2 | $428K | Hold |
4,624
| – | – | 0.16% | 57 |
|
|
2018
Q1 | $438K | Hold |
4,624
| – | – | 0.16% | 52 |
|
|
2017
Q4 | $447K | Hold |
4,624
| – | – | 0.16% | 49 |
|
|
2017
Q3 | $411K | Buy |
4,624
+38
| +0.8% | +$2.89K | 0.15% | 52 |
|
|
2017
Q2 | $333K | Buy |
4,586
+41
| +0.9% | +$2.76K | 0.12% | 54 |
|
|
2017
Q1 | $296K | Buy |
4,545
+44
| +1% | +$2.77K | 0.11% | 56 |
|
|
2016
Q4 | $282K | Buy |
4,501
+38
| +0.9% | +$2.32K | 0.11% | 56 |
|
|
2016
Q3 | $282K | Buy |
4,463
+34
| +0.8% | +$2.2K | 0.11% | 56 |
|
|
2016
Q2 | $274K | Buy |
4,429
+38
| +0.9% | +$2.31K | 0.11% | 56 |
|
|
2016
Q1 | $251K | Buy |
4,391
+43
| +1% | +$2.4K | 0.1% | 60 |
|
|
2015
Q4 | $258K | Buy |
4,348
+34
| +0.8% | +$1.96K | 0.11% | 63 |
|
|
2015
Q3 | $235K | Buy |
4,314
+30
| +0.7% | +$1.95K | 0.1% | 64 |
|
|
2015
Q2 | $288K | Buy |
+4,284
| New | +$280K | 0.12% | 60 |
|
Other funds holding ABBV
VCM
VPM
Lafayette Investments's ABBV Position: Q1 2026 in Review
Lafayette Investments held its AbbVie (ABBV) position steady in Q1 2026 at 1,691 shares worth $368K. The position accounts for 0.07% of the portfolio, ranked #118.
Lafayette Investments first reported a position in ABBV in Q2 2015 and has held it in 37 quarters since. The position peaked at $983K in Q4 2018. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Lafayette Investments held 1,691 shares of AbbVie worth $368K as of Q1 2026.
- Lafayette Investments left its AbbVie share count unchanged in Q1 2026.
- AbbVie made up 0.07% of Lafayette Investments's portfolio in Q1 2026, its #118 holding.
- Lafayette Investments first reported a position in AbbVie in Q2 2015 and has held it in 37 quarters since.
- Lafayette Investments's AbbVie position peaked at $983K in Q4 2018.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Lafayette Investments's 13F filing for Q1 2026, filed 27 Apr 2026.